v产品详情
|
产品英文名 |
Anti-GDF-15 antibody |
|
克隆类型 |
单克隆抗体/Monoclonal |
|
生产方式 |
重组表达 |
|
标记方式 |
非偶联/Unconjugated |
|
抗体亚型 |
Human IgG1/κ |
|
免疫原序列 |
GDF15 |
|
缓冲液 |
PBS, pH 7.4 |
|
纯度 |
>95% Determined by SDS-PAGE |
|
分子量 |
150 kDa |
|
应用 |
in vitro GDF-15 neutralization in vivo blocking of GDF-15 signaling in vitro functional assay in vivo functional assay |
|
纯化方式 |
Protein A |
| 内毒素水平 | <1EU/mg (<0.001EU/μg) Determined by LAL gel clotting assay |
| 灭菌 | 0.2 µm filtration |
|
储存条件 |
4°C储存，避免冷冻 |
|
运输方式 |
蓝冰 |
v文件资料
|
|
v相关文献
|
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours|Melero, I., de Miguel Luken, M., de Velasco, G. et al. Nature 637, 1218–1227 (January30,2025). |
